Seminoma patients with high SLC5A5 expression had a markedly increased risk of recurrence, with an approximately tenfold greater risk compared to those with low expression (p = 0.032, HR = 10.31, 95% CI: 1.275–83.344). Here, SLC5A5 is linked to seminoma.